First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.227 USD -3.81% Market Closed
Updated: May 21, 2024

Sonoma Pharmaceuticals Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Free Cash Flow Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Free Cash Flow
-$5.2m
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
0%
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$18.7B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$12.5B
CAGR 3-Years
-2%
CAGR 5-Years
19%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$5.1B
CAGR 3-Years
-27%
CAGR 5-Years
-17%
CAGR 10-Years
-11%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$11B
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
-$3.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sonoma Pharmaceuticals Inc's Free Cash Flow?
Free Cash Flow
-5.2m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Free Cash Flow amounts to -5.2m USD.

What is Sonoma Pharmaceuticals Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%

Over the last year, the Free Cash Flow growth was 1%. The average annual Free Cash Flow growth rates for Sonoma Pharmaceuticals Inc have been 3% over the past three years , 16% over the past five years .